Do patients whose tumor achieved a pathological response relapse at specific sites? A substudy of the EORTC 10994/BIG-1-00 trial

Kim C. Aalders, Nathan Touati, Konstantinos Tryfonidis, Mylène Annonay, Saskia Litiere, Jonas Bergh, Alexandre Bodmer, David A. Cameron, Hervé R. Bonnefoi

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalBreast cancer research and treatment
Publication statusPublished - 12 Feb 2018


  • breast cancer
  • Pathological complete responsesponse
  • Neoadjuvant chemotherapy
  • relapse
  • metastases
  • patterns

Cite this